Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study

Specific coffee subtypes and tea may impact risk of pre- and post-menopausal breast cancer differently. We investigated the association between coffee (total, caffeinated, decaffeinated) and tea intake and risk of breast cancer. A total of 335,060 women participating in the European Prospective Inve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast cancer research : BCR 2015-01, Vol.17 (1), p.15-15, Article 15
Hauptverfasser: Bhoo-Pathy, Nirmala, Peeters, Petra H M, Uiterwaal, Cuno S P M, Bueno-de-Mesquita, H Bas, Bulgiba, Awang M, Bech, Bodil Hammer, Overvad, Kim, Tjønneland, Anne, Olsen, Anja, Clavel-Chapelon, Françoise, Fagherazzi, Guy, Perquier, Florence, Teucher, Birgit, Kaaks, Rudolf, Schütze, Madlen, Boeing, Heiner, Lagiou, Pagona, Orfanos, Philippos, Trichopoulou, Antonia, Agnoli, Claudia, Mattiello, Amalia, Palli, Domenico, Tumino, Rosario, Sacerdote, Carlotta, van Duijnhoven, Franzel J B, Braaten, Tonje, Lund, Eiliv, Skeie, Guri, Redondo, María-Luisa, Buckland, Genevieve, Pérez, Maria José Sánchez, Chirlaque, Maria-Dolores, Ardanaz, Eva, Amiano, Pilar, Wirfält, Elisabet, Wallström, Peter, Johansson, Ingegerd, Nilsson, Lena Maria, Khaw, Kay-Tee, Wareham, Nick, Allen, Naomi E, Key, Timothy J, Rinaldi, Sabina, Romieu, Isabelle, Gallo, Valentina, Riboli, Elio, van Gils, Carla H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Specific coffee subtypes and tea may impact risk of pre- and post-menopausal breast cancer differently. We investigated the association between coffee (total, caffeinated, decaffeinated) and tea intake and risk of breast cancer. A total of 335,060 women participating in the European Prospective Investigation into Nutrition and Cancer (EPIC) Study, completed a dietary questionnaire from 1992 to 2000, and were followed-up until 2010 for incidence of breast cancer. Hazard ratios (HR) of breast cancer by country-specific, as well as cohort-wide categories of beverage intake were estimated. During an average follow-up of 11 years, 1064 premenopausal, and 9134 postmenopausal breast cancers were diagnosed. Caffeinated coffee intake was associated with lower risk of postmenopausal breast cancer: adjusted HR=0.90, 95% confidence interval (CI): 0.82 to 0.98, for high versus low consumption; Ptrend=0.029. While there was no significant effect modification by hormone receptor status (P=0.711), linear trend for lower risk of breast cancer with increasing caffeinated coffee intake was clearest for estrogen and progesterone receptor negative (ER-PR-), postmenopausal breast cancer (P=0.008). For every 100 ml increase in caffeinated coffee intake, the risk of ER-PR- breast cancer was lower by 4% (adjusted HR: 0.96, 95% CI: 0.93 to 1.00). Non-consumers of decaffeinated coffee had lower risk of postmenopausal breast cancer (adjusted HR=0.89; 95% CI: 0.80 to 0.99) compared to low consumers, without evidence of dose-response relationship (Ptrend=0.128). Exclusive decaffeinated coffee consumption was not related to postmenopausal breast cancer risk, compared to any decaffeinated-low caffeinated intake (adjusted HR=0.97; 95% CI: 0.82 to 1.14), or to no intake of any coffee (HR: 0.96; 95%: 0.82 to 1.14). Caffeinated and decaffeinated coffee were not associated with premenopausal breast cancer. Tea intake was neither associated with pre- nor post-menopausal breast cancer. Higher caffeinated coffee intake may be associated with lower risk of postmenopausal breast cancer. Decaffeinated coffee intake does not seem to be associated with breast cancer.
ISSN:1465-542X
1465-5411
1465-542X
DOI:10.1186/s13058-015-0521-3